4//SEC Filing
ARCH Venture Partners IX, LLC 4
Accession 0000899243-19-018905
CIK 0001771917other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:09 PM ET
Size
34.5 KB
Accession
0000899243-19-018905
Insider Transaction Report
Form 4
ARCH Venture Partners IX, LLC
10% Owner
Transactions
- Conversion
Common Stock
2019-07-02+857,793→ 1,681,437 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,206→ 0 total(indirect: See Footnote)→ Common Stock (723,643 underlying) - Conversion
Series B Preferred Stock
2019-07-02−660,501→ 0 total(indirect: See Footnote)→ Common Stock (857,792 underlying) - Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+723,643→ 823,643 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,207→ 0 total(indirect: See Footnote)→ Common Stock (723,644 underlying) - Conversion
Common Stock
2019-07-02+723,644→ 823,644 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+857,792→ 1,681,435 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2019-07-02−660,502→ 0 total(indirect: See Footnote)→ Common Stock (857,793 underlying) - Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote)
ARCH Venture Fund IX, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2019-07-02+723,643→ 823,643 total(indirect: See Footnote) - Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+857,792→ 1,681,435 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,206→ 0 total(indirect: See Footnote)→ Common Stock (723,643 underlying) - Conversion
Common Stock
2019-07-02+857,793→ 1,681,437 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2019-07-02−660,502→ 0 total(indirect: See Footnote)→ Common Stock (857,793 underlying) - Conversion
Common Stock
2019-07-02+723,644→ 823,644 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,207→ 0 total(indirect: See Footnote)→ Common Stock (723,644 underlying) - Conversion
Series B Preferred Stock
2019-07-02−660,501→ 0 total(indirect: See Footnote)→ Common Stock (857,792 underlying)
BYBEE CLINTON
10% Owner
Transactions
- Conversion
Common Stock
2019-07-02+857,793→ 1,681,437 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2019-07-02−660,502→ 0 total(indirect: See Footnote)→ Common Stock (857,793 underlying) - Conversion
Common Stock
2019-07-02+723,643→ 823,643 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,207→ 0 total(indirect: See Footnote)→ Common Stock (723,644 underlying) - Conversion
Series A Preferred Stock
2019-07-02−557,206→ 0 total(indirect: See Footnote)→ Common Stock (723,643 underlying) - Conversion
Series B Preferred Stock
2019-07-02−660,501→ 0 total(indirect: See Footnote)→ Common Stock (857,792 underlying) - Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+723,644→ 823,644 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+857,792→ 1,681,435 total(indirect: See Footnote)
ARCH Venture Partners IX, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+723,644→ 823,644 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+723,643→ 823,643 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,207→ 0 total(indirect: See Footnote)→ Common Stock (723,644 underlying) - Conversion
Series B Preferred Stock
2019-07-02−660,501→ 0 total(indirect: See Footnote)→ Common Stock (857,792 underlying) - Conversion
Series A Preferred Stock
2019-07-02−557,206→ 0 total(indirect: See Footnote)→ Common Stock (723,643 underlying) - Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+857,792→ 1,681,435 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+857,793→ 1,681,437 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2019-07-02−660,502→ 0 total(indirect: See Footnote)→ Common Stock (857,793 underlying)
Transactions
- Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,206→ 0 total(indirect: See Footnote)→ Common Stock (723,643 underlying) - Conversion
Series B Preferred Stock
2019-07-02−660,501→ 0 total(indirect: See Footnote)→ Common Stock (857,792 underlying) - Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+857,793→ 1,681,437 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,207→ 0 total(indirect: See Footnote)→ Common Stock (723,644 underlying) - Conversion
Series B Preferred Stock
2019-07-02−660,502→ 0 total(indirect: See Footnote)→ Common Stock (857,793 underlying) - Conversion
Common Stock
2019-07-02+857,792→ 1,681,435 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+723,644→ 823,644 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+723,643→ 823,643 total(indirect: See Footnote)
CRANDELL KEITH
10% Owner
Transactions
- Conversion
Common Stock
2019-07-02+723,644→ 823,644 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,206→ 0 total(indirect: See Footnote)→ Common Stock (723,643 underlying) - Conversion
Series B Preferred Stock
2019-07-02−660,501→ 0 total(indirect: See Footnote)→ Common Stock (857,792 underlying) - Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+857,793→ 1,681,437 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2019-07-02−660,502→ 0 total(indirect: See Footnote)→ Common Stock (857,793 underlying) - Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,207→ 0 total(indirect: See Footnote)→ Common Stock (723,644 underlying) - Conversion
Common Stock
2019-07-02+723,643→ 823,643 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+857,792→ 1,681,435 total(indirect: See Footnote)
ARCH Venture Fund IX Overage, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+723,644→ 823,644 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+723,643→ 823,643 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+857,792→ 1,681,435 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,206→ 0 total(indirect: See Footnote)→ Common Stock (723,643 underlying) - Conversion
Series B Preferred Stock
2019-07-02−660,501→ 0 total(indirect: See Footnote)→ Common Stock (857,792 underlying) - Purchase
Common Stock
2019-07-02$16.00/sh+100,000$1,600,000→ 100,000 total(indirect: See Footnote) - Conversion
Common Stock
2019-07-02+857,793→ 1,681,437 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-07-02−557,207→ 0 total(indirect: See Footnote)→ Common Stock (723,644 underlying) - Conversion
Series B Preferred Stock
2019-07-02−660,502→ 0 total(indirect: See Footnote)→ Common Stock (857,793 underlying)
Footnotes (4)
- [F1]These shares are directly held by ARCH Venture Fund IX, L.P. ("ARCH IX"). ARCH Venture Partners IX, L.P. ("GPLP"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the "ARCH Managing Directors"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
- [F2]These shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
- [F3]The Series A Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock. The Series A Preferred Stock has no expiration date.
- [F4]The Series B Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock. The Series B Preferred Stock has no expiration date.
Documents
Issuer
Karuna Therapeutics, Inc.
CIK 0001771917
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001723174
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:09 PM ET
- Size
- 34.5 KB